NCT02036320

Brief Summary

The purpose of this clinical trial is to compare the overall lens fit acceptance of two different soft contact lenses in an Asian population.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable

Geographic Reach
2 countries

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 10, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 15, 2014

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

October 5, 2015

Completed
Last Updated

June 19, 2018

Status Verified

September 1, 2015

Enrollment Period

1 month

First QC Date

January 10, 2014

Results QC Date

September 3, 2015

Last Update Submit

June 18, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mechanical Lens Fit Acceptance

    The number of subject eyes that were classified as having acceptable mechanical lens fit, with a slit lamp.

    15 mins post insertion

  • Cosmetic Lens Fit Acceptance

    The number of subject eyes that were classified as having acceptable cosmetic lens fit in primary gaze, without a slit lamp.

    15 mins post insertion

  • Lens Does Not Exhibit "Hula Hoop" Effect

    The number of subjects that did not exhibit a "hula hoop" effect as recorded by Eye Care Practitioner (ECP) judgment of acceptable physiology, in primary gaze, without a slit lamp.

    15 mins post insertion

Study Arms (2)

etafilcon A with additive printed limbal ring

EXPERIMENTAL

Each subject will insert the trial lens while being observed by a technician prior to assessment by the study investigator.

Device: etafilcon A

etafilcon A

ACTIVE COMPARATOR

Each subject will insert the trial lens while being observed by a technician prior to assessment by the study investigator.

Device: etafilcon A

Interventions

Each study subject will be exposed to both test lenses following a washout period of five minutes between test periods.

etafilcon Aetafilcon A with additive printed limbal ring

Eligibility Criteria

Age18 Years - 41 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The subject must read, understand, and sign the statement of informed consent and receive a fully executed copy of the form.
  • The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.
  • The subject must be an Asian female (self-reported).
  • The subject must be at least 18 years old and less than 41 years old.
  • The subject must meet two of the four East Asian anatomical categories (Appendix D) and have a prominent epicanthic fold to be classified East Asian ethnicity. For the purpose of this protocol, East Asian ethnicities may include: China, Japan, Korea, Taiwan, Vietnam, Hong Kong, Malaysia, and Singapore but are not inclusive of these regions.
  • The subject must be a habitual soft contact lens wearer. Habitual is defined as: at least one month of daily wear where the lenses are worn a minimum of six (6) hours per day and a minimum of three (3) days per week prior to enrollment in the study.
  • The subject's optimal non-vertexed spherical equivalent distance correction (based on their optimal sphero-cylinder refraction) must be between +2.00 D and -12.00 D.
  • Any cylinder power must be less than or equal to -1.00 D confirmed by refraction.
  • The subject must possess a functional/usable pair of spectacles and wear them to the visit (only if applicable-to the investigator's discretion).
  • The subject's best correctable visual acuity is 20/40 or better (OD and OS) at the baseline visit.

You may not qualify if:

  • Ocular or systemic allergies which might interfere with contact lens wear.
  • Ocular or systemic disease which might interfere with contact lens wear.
  • Any known hypersensitivity or allergic reaction to contact lenses or contact lens solutions.
  • Use of any ocular or topical medication.
  • Use of any systemic (oral) medication that is taken for an ocular condition which might interfere with contact lens wear.
  • Use of any systemic (oral) medication that is taken for a systemic condition which might interfere with the contact lens wear (this determination will be at the discretion of the investigator).
  • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection or any other abnormalities of the cornea and/or conjunctiva which would contraindicate contact lens wear.
  • Rigid gas permeable or hybrid design (rigid gas permeable center and a soft lens skirt) contact lens wear within the past 30 days.
  • Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.
  • Any previous or planned (during duration of the study), ocular or intraocular surgery (e.g. radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), peripheral iridotomy, etc.)
  • Pregnancy or lactation.
  • Diabetes.
  • Infectious disease.
  • Habitual contact lens type is multifocal, monovision or worn as extended wear.
  • Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Unknown Facility

Berkeley, California, 94720, United States

Location

Unknown Facility

Fullerton, California, 92831, United States

Location

Unknown Facility

New York, New York, 12207, United States

Location

Unknown Facility

Cleveland, Ohio, 44106, United States

Location

Unknown Facility

Dallas, Texas, 75390, United States

Location

Unknown Facility

Houston, Texas, 77204, United States

Location

Unknown Facility

Waterloo, Ontario, N2L 3G1, Canada

Location

Results Point of Contact

Title
Meredith Jansen,O.D.,M.S., FAAO
Organization
Johnson and Johnson Vision Care Inc.

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2014

First Posted

January 15, 2014

Study Start

January 1, 2014

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

June 19, 2018

Results First Posted

October 5, 2015

Record last verified: 2015-09

Locations